Synapse - Khadeja A Moses

Khadeja A Moses

Research Focus

Medicine; Clinical Research Associate

Recent additions – View all

Osimertinib, platinum, etoposide as initial treatment for patients with EGFR mutant lung cancers with TP53 and RB1 alterations
Meeting Abstract

Chen, M. F.; Rakhade, S.; Quintanal-Villalonga, A.; Lee, J.; Forsythe, B.; Moses, K. A.; Ahn, L. S. H.; Pupo, A.; Falcon, C. J.; Rekhtman, N.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save
Phase II study of cabozantinib in patients with MET-altered lung cancers
Meeting Abstract

Harada, G.; Santini, F. C.; Repetti, R. W.; Chang, J.; Yang, S. R.; Lin, Y. T.; Moses, K. A.; Falcon, C.; Wilhelm, C. J.; Goldstein, M.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save
Brief report: Combination of osimertinib and dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas
Journal Article

Elkrief, A.; Makhnin, A.; Moses, K. A.; Ahn, L. S.; Preeshagul, I. R.; Iqbal, A. N.; Hayes, S. A.; Plodkowski, A. J.; Paik, P. K.; Ladanyi, M.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Co-authors at MSK

3

Kris
2

Ahn
2

Falcon
2

Makhnin
2

Plodkowski
2

Yu
1

Chang
1

Chan
1

Chen
1

Drilon
1

Elkrief
1

Forsyth
1

Ginsberg
1

Goldstein
1

Harada
1

Hayes
1

Iqbal
1

Ladanyi
1

Lin
1

Paik
1

Preeshagul
1

Pupo
1

Quintan...
1

Rekhtman
1

Repetti
1

Riely
1

Rudin
1

Santini
1

Wilhelm
1

Yang

Types of Work

Publications